Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
J Surg Oncol
    June 2018
  1. FUJIMOTO Y, Higuchi T, Nishimukai A, Miyagawa Y, et al
    High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.
    J Surg Oncol. 2018 Jun 24. doi: 10.1002/jso.25125.
    >> Share

    May 2018
  2. SHEN S, Xu Q, Zhou Y, Mao F, et al
    Comparison of sentinel lymph node biopsy guided by blue dye with or without indocyanine green in early breast cancer.
    J Surg Oncol. 2018 May 22. doi: 10.1002/jso.25058.
    >> Share

    April 2018
  3. VOLDERS JH, Negenborn VL, Haloua MH, Krekel NMA, et al
    Breast-specific factors determine cosmetic outcome and patient satisfaction after breast-conserving therapy: Results from the randomized COBALT study.
    J Surg Oncol. 2018;117:1001-1008.
    >> Share

    March 2018
    Breast cancer subtypes and local recurrence rate after surgery for bone metastasis to the extremities.
    J Surg Oncol. 2018 Mar 30. doi: 10.1002/jso.24987.
    >> Share

  5. FOSTER D, Choy N, Porter C, Ahmed S, et al
    Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    J Surg Oncol. 2018;117:336-340.
    >> Share

  6. SO A, De La Cruz LM, Williams AD, Bahng J, et al
    The impact of preoperative magnetic resonance imaging and lumpectomy cavity shavings on re-excision rate in pure ductal carcinoma in situ-A single institution's experience.
    J Surg Oncol. 2018;117:558-566.
    >> Share

    February 2018
  7. PERCY DB, Pao JS, McKevitt E, Dingee C, et al
    Number of nodes in sentinel lymph node biopsy for breast cancer: Are surgeons still biased?
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25010.
    >> Share

    December 2017
  8. GERVAIS MK, Burtenshaw SM, Maxwell J, Dickson BC, et al
    Clinical outcomes in breast angiosarcoma patients: A rare tumor with unique challenges.
    J Surg Oncol. 2017;116:1056-1061.
    >> Share

  9. GIANNINI V, Bianchi V, Carabalona S, Mazzetti S, et al
    MRI to predict nipple-areola complex (NAC) involvement: An automatic method to compute the 3D distance between the NAC and tumor.
    J Surg Oncol. 2017;116:1069-1078.
    >> Share

  10. ALVARADO M, Lucci A, Manders J
    Best practices for multidisciplinary integration of a DCIS genomic assay into clinical practice.
    J Surg Oncol. 2017;116:1016-1020.
    >> Share

  11. PATTEN CR, Walsh K, Sarantou T, Hadzikadic-Gusic L, et al
    Changes in margin re-excision rates: Experience incorporating the "no ink on tumor" guideline into practice.
    J Surg Oncol. 2017;116:1040-1045.
    >> Share

  12. HWANG H, Park S, Koo JS, Park HS, et al
    Factors predictive of occult nipple-areolar complex involvement in patients with carcinoma in situ of the breast.
    J Surg Oncol. 2017;116:1046-1055.
    >> Share

    November 2017
  13. TATARA T, Mukohara T, Shimono Y, Yamasaki T, et al
    Expression of programmed death-1 in sentinel lymph nodes of breast cancer.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24937.
    >> Share

  14. ONEGA T, Weiss JE, Goodrich ME, Zhu W, et al
    Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer.
    J Surg Oncol. 2017 Nov 11. doi: 10.1002/jso.24796.
    >> Share

    October 2017
  15. LEE S, Jung Y, Bae Y
    Immediate chest wall reconstruction using an external oblique myocutaneous flap for large skin defects after mastectomy in advanced or recurrent breast cancer patients: A single center experience.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24830.
    >> Share

    Is HER2 loss after neoadjuvant chemotherapy determinant for the choice of adjuvant treatment in HER2 positive breast cancer patients?
    J Surg Oncol. 2017 Oct 2. doi: 10.1002/jso.24839.
    >> Share

    September 2017
  17. NOGUCHI M, Ohno Y, Morioka E, Noguchi M, et al
    A novel oncoplastic technique for breast cancer localized in the lower pole of the breast.
    J Surg Oncol. 2017 Sep 20. doi: 10.1002/jso.24824.
    >> Share

    August 2017
  18. YANG EJ, Kwon Y
    Changes in shoulder muscle activity pattern on surface electromyography after breast cancer surgery.
    J Surg Oncol. 2017 Aug 22. doi: 10.1002/jso.24800.
    >> Share

  19. YOSHIDA A, Hayashi N, Suzuki K, Takimoto M, et al
    Change in HER2 status after neoadjuvant chemotherapy and the prognostic impact in patients with primary breast cancer.
    J Surg Oncol. 2017 Aug 2. doi: 10.1002/jso.24762.
    >> Share

    July 2017
  20. WEVERS MR, Aaronson NK, Bleiker EMA, Hahn DEE, et al
    Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making.
    J Surg Oncol. 2017 Jul 13. doi: 10.1002/jso.24763.
    >> Share

  21. UNKART JT, Hosseini A, Wallace AM
    Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: Results from a randomized, blinded clinical trial.
    J Surg Oncol. 2017 Jul 10. doi: 10.1002/jso.24735.
    >> Share

  22. HAGE AN, Capriccioso C, Brennan J, Heiden B, et al
    Impact of neoadjuvant chemotherapy on surgical outcomes among patients with hormone receptor positive breast cancer.
    J Surg Oncol. 2017 Jul 3. doi: 10.1002/jso.24721.
    >> Share

    June 2017
  23. BARGALLO-ROCHA JE, Soto-Perez-de-Celis E, Pico-Guzman FJ, Quintero-Rodriguez CE, et al
    The impact of the use of intraoperative radiotherapy on costs, travel time and distance for women with breast cancer in the Mexico City Metropolitan Area.
    J Surg Oncol. 2017 Jun 12. doi: 10.1002/jso.24712.
    >> Share

  24. SZYNGLAREWICZ B, Kasprzak P, Donizy P, Biecek P, et al
    Epithelial-mesenchymal transition inducer Snail1 and invasive potential of intraductal breast cancer.
    J Surg Oncol. 2017 Jun 1. doi: 10.1002/jso.24708.
    >> Share

  25. HANDA T, Katayama A, Yokobori T, Yamane A, et al
    Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.
    J Surg Oncol. 2017 Jun 1. doi: 10.1002/jso.24705.
    >> Share

    May 2017
    Multigene assays: Implications for breast cancer staging.
    J Surg Oncol. 2017 May 11. doi: 10.1002/jso.24568.
    >> Share

    April 2017
  27. TSENG J, Kyrillos A, Liederbach E, Spear GG, et al
    Clinical accuracy of preoperative breast MRI for breast cancer.
    J Surg Oncol. 2017 Apr 13. doi: 10.1002/jso.24616.
    >> Share

  28. BEAR HD, Wan W, Robidoux A, Rubin P, et al
    Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.
    J Surg Oncol. 2017 Apr 13. doi: 10.1002/jso.24610.
    >> Share

    March 2017
  29. VIEIRA RA, da Silva KM, de Oliveira-Junior I, de Lima MA, et al
    ITADE flap after mastectomy for locally advanced breast cancer: A good choice for mid-sized defects of the chest wall, based on a systematic review of thoracoabdominal flaps.
    J Surg Oncol. 2017 Mar 27. doi: 10.1002/jso.24619.
    >> Share

  30. NING K, Wang T, Sun X, Zhang P, et al
    UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer.
    J Surg Oncol. 2017 Mar 23. doi: 10.1002/jso.24614.
    >> Share

  31. GERVAIS MK, Maki E, Schiller DE, Crystal P, et al
    Preoperative MRI of the breast and ipsilateral breast tumor recurrence: Long-term follow up.
    J Surg Oncol. 2017;115:231-237.
    >> Share

  32. SCHULZ-WENDTLAND R, Harz M, Meier-Meitinger M, Brehm B, et al
    Semi-automated delineation of breast cancer tumors and subsequent materialization using three-dimensional printing (rapid prototyping).
    J Surg Oncol. 2017;115:238-242.
    >> Share

    February 2017
  33. HYAMS DM, Schuur E, Angel Aristizabal J, Bargallo Rocha JE, et al
    Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays.
    J Surg Oncol. 2017 Feb 17. doi: 10.1002/jso.24561.
    >> Share

  34. VERDIAL FC, Etzioni R, Duggan C, Anderson BO, et al
    Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screening.
    J Surg Oncol. 2017 Feb 14. doi: 10.1002/jso.24579.
    >> Share

  35. ALCANTARA VS, Lim GH, Lim SH, Sultana R, et al
    Incidence and prognosis of non-metastatic triple negative breast cancer (TNBC) among different races in Southeast Asia.
    J Surg Oncol. 2017 Feb 7. doi: 10.1002/jso.24559.
    >> Share

  36. FREITAS-JUNIOR R, Gagliato DM, Moura Filho JW, Gouveia PA, et al
    Trends in breast cancer surgery at Brazil's public health system.
    J Surg Oncol. 2017 Feb 6. doi: 10.1002/jso.24572.
    >> Share

  37. LEBYA K, Garcia-Smith R, Swaminathan R, Jones A, et al
    Towards a personalized surgical margin for breast conserving surgery-Implications of field cancerization in local recurrence.
    J Surg Oncol. 2017;115:109-115.
    >> Share

  38. VU JV, Llarena NC, Estevez SL, Moravek MB, et al
    Oncofertility program implementation increases access to fertility preservation options and assisted reproductive procedures for breast cancer patients.
    J Surg Oncol. 2017;115:116-121.
    >> Share

    January 2017
  39. YIP CH
    Palliation and breast cancer.
    J Surg Oncol. 2017 Jan 18. doi: 10.1002/jso.24560.
    >> Share

  40. ACEA-NEBRIL B, Cereijo-Garea C, Garcia-Novoa A, Varela-Lamas C, et al
    The role of oncoplastic breast reduction in the conservative management of breast cancer: Complications, survival, and quality of life.
    J Surg Oncol. 2017 Jan 13. doi: 10.1002/jso.24550.
    >> Share

  41. QUAN ML, Paszat LF, Fernandes KA, Sutradhar R, et al
    The effect of surgery type on survival and recurrence in very young women with breast cancer.
    J Surg Oncol. 2017 Jan 5. doi: 10.1002/jso.24489.
    >> Share

    December 2016
  42. KARANLIK H, Ozgur I, Kilic B, Fathalizadeh A, et al
    Sentinel lymph node biopsy and aberrant lymphatic drainage in recurrent breast cancer: Findings likely to change treatment decisions.
    J Surg Oncol. 2016;114:796-802.
    >> Share

  43. DOSSETT LA, Abbott AM, Sun W, Loftus L, et al
    Factors predictive of failure to complete planned intraoperative breast radiation using the intrabeam(R) system.
    J Surg Oncol. 2016;114:930-932.
    >> Share

    November 2016
  44. VAN BOMMEL AC, Spronk PE, Vrancken Peeters MT, Jager A, et al
    Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit.
    J Surg Oncol. 2016 Nov 25. doi: 10.1002/jso.24516.
    >> Share

    October 2016
  45. ROBINSON JD, Venetis M, Street RL Jr, Kearney T, et al
    Breast cancer patients' information seeking during surgical consultations: A qualitative, videotape-based analysis of patients' questions.
    J Surg Oncol. 2016 Oct 12. doi: 10.1002/jso.24470.
    >> Share

  46. SZYNGLAREWICZ B, Kasprzak P, Donizy P, Biecek P, et al
    Ductal carcinoma in situ on stereotactic biopsy of suspicious breast microcalcifications: Expression of SPARC (Secreted Protein, Acidic and Rich in Cysteine) can predict postoperative invasion.
    J Surg Oncol. 2016;114:548-556.
    >> Share

    July 2016
  47. HUANG BZ, Camp MS
    Burden of preoperative cardiovascular disease risk factors on breast cancer surgery outcomes.
    J Surg Oncol. 2016 Jul 8. doi: 10.1002/jso.24298.
    >> Share

  48. SEWARD C, Skolny M, Brunelle C, Asdourian M, et al
    A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema.
    J Surg Oncol. 2016 Jul 8. doi: 10.1002/jso.24365.
    >> Share

  49. CARAGACIANU DL, Mayer EL, Chun YS, Caterson S, et al
    Immediate breast reconstruction following mastectomy in pregnant women with breast cancer.
    J Surg Oncol. 2016 Jul 8. doi: 10.1002/jso.24308.
    >> Share

    May 2016
  50. PARK HS, Heo I, Kim JY, Kim S, et al
    No effect of tumor-infiltrating lymphocytes (TILs) on prognosis in patients with early triple-negative breast cancer: Validation of recommendations by the International TILs Working Group 2014.
    J Surg Oncol. 2016 May 8. doi: 10.1002/jso.24275.
    >> Share

    March 2016
  51. MIRANDA GARCES M, Mirapeix R, Pons G, Sadri A, et al
    A comprehensive review of the natural lymphaticovenous communications and their role in lymphedema surgery.
    J Surg Oncol. 2016;113:374-80.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016